Abbott Laboratories v. Feinberg
This text of Abbott Laboratories v. Feinberg (Abbott Laboratories v. Feinberg) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
an 745 Fifth Avenue, 5th Floor, New York, NY 10151 eS G ROSSMAN LLP T. 646-770-7445 F, 646-417-7997 a ATTORNEYS AT LAW GROSSMANLLP.COM
USDC SDNY February 28, 2020 DOCUMENT ELECTRONICALLY FILED VIA ECF DOC #: DATE FILED:_ 3/2/2020 Hon. Lorna G. Schofield United States District Judge United States District Court, Southern District of New York 500 Pearl Street New York, New York 10007 Re: Abbott Laboratories v. Carol Feinberg, Case No. 18 Civ. 8468 (LGS) Dear Judge Schofield, We write on behalf of Plaintiff Abbott Laboratories (“Abbott”) under Section I.D.3 of the Court’s Individual Rules and Procedures for Civil Cases to respectfully request the Court’s permission to file Exhibits 1, 2, and 5 to the February 28, 2020, Declaration of Judd B. Grossman, Esq. (the “Grossman Declaration”) in opposition to Defendants’ choice-of-law motion (Dkt. 97) in redacted form and under seal. These redactions are narrowly tailored to maintain confidentiality of the following limited categories of information: (1) the identity of various artworks; and (2) personal contact information of non-party witnesses. The parties agreed at the outset of this case—consistent with the practice in many high- end-art disputes—to redact the identity of the artist and the title and description of the Painting at issue to avoid further casting a cloud on its title. This Court previously allowed such redactions that were “narrowly tailored and necessary to prevent the disclosure of information that could unnecessarily impair the value of the artwork.” (August 28, 2019, Order, Dkt. No. 72; see August 21, 2019, Order, Dkt. No. 70; May 13, 2019, Order, Dkt. No. 46.) For these same reasons, Abbott again seeks permission to redact the identity of the Painting, as well as several other artworks. Abbott also seeks to redact the home addresses of two non-party witnesses, where this personal information is not relevant to the claims or defenses at issue. For these reasons, Abbott respectfully requests that the Court permit Abbott to file Exhibits 1, 2, and 5 to the Grossman Declaration in redacted form and under seal.
GRANTED. laintiff may file Exhibits 1, 2, and 5 to the Grossman Declaration in opposition to Defendants’ choice-of-law in redacted form and under seal. The Court has reviewed the materials, and the proposed redactions re narrowly tailored to prevent the disclosure of information that could unnecessarily impair the value of the rtwork, and to prevent the disclosure pf private information irrelevant to the claims or defenses at issue. See CSL Silicones, Inc. v. Midsun Grp. Inc., No. 3:14 Civ. 1897, 2017 WL 4750701, at *4 (D. Conn. July 12, 2017) for redactions of "commercially sensitive" information). March 2, 2020 © New York, New York
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Abbott Laboratories v. Feinberg, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbott-laboratories-v-feinberg-nysd-2020.